HEARTLEIN MICHAEL enters TRANSLATE BIO, INC. with 18K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/27/2018ACC: 0000899243-18-018418
OfficerOther· Chief Scientific Officer
Since Mar 2019
18K
Baseline shares
100% direct
18K
Direct ownership
1 position
400.70K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned18K
Total
18K direct18K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18K | Direct |
| Total | 18K | 18K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
30K
Shares owned
N/A
Exercise price
8.34
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
370.69K
Shares owned
N/A
Exercise price
7.06
Expiration
—
Exercise window
—
Total
Underlying
400.70K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 8.34 | — | — | 30K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 7.06 | — | — | 370.69K | N/A |
| Total | 400.70K | 0.00 | ||||